MedPath

Artificial Intelligence to Measure Adherence to Oral Medication

Phase 4
Recruiting
Conditions
First Episode Psychosis
Registration Number
NCT04046497
Lead Sponsor
Northwell Health
Brief Summary

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Detailed Description

The challenge of oral medication adherence in first-episode psychosis (as in any potentially chronic illness) is enormous, and numerous studies have linked non-adherence to increased rates of relapse/ hospitalization. Determining whether a patient is adhering to medication is a challenge. Pill counts, pharmacy records, technology-assisted monitoring, biological assays, and a range of self-report and interviewer-rated scales have been employed. In other areas of medicine such as antiretroviral treatment Direct Observation of Treatment (DOT) has been employed with excellent success both in monitoring and demonstrated improvement of important clinical outcomes. DOT is clearly not feasible in community settings. An artificial Intelligence (AI) platform that can be downloaded as an application onto a smart phone app represents a novel approach to offering DOT to support participant oral medication adherence and thereby improve outcomes. Aims of the project are: 1) to document acceptability to patients of the AI smartphone app based upon participation in the study and 2) to compare rates of hospitalization and emergency room visits between participants who receive the AI smartphone app with participants who receive standard care.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Enrolled in a CSC program
  • Prescribed an oral antipsychotic
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Service Utilization Report Form12 months

Provides participant utilization of psychiatric ER visits or psychiatric hospitalization

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Citrus Health

🇺🇸

Hialeah, Florida, United States

InterAct

🇺🇸

Grand Rapids, Michigan, United States

InterAct of Michigan

🇺🇸

Kalamazoo, Michigan, United States

Red Rock

🇺🇸

Oklahoma City, Oklahoma, United States

Family and Children's Services

🇺🇸

Tulsa, Oklahoma, United States

Citrus Health
🇺🇸Hialeah, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.